Moreover, as the interaction of KIR2DL5 with PVR has been demonstrated to inhibit NK cell functions [88] and PVR is highly expressed on the surface of AML cells, selecting a donor with a KIR AA genotype seems to be a more effective strategy for the elimination of AML cells [88, 171]. Here, PVR is linked to acute myeloid leukemia.